Table 1.
Patient Characteristics.
| Valid Cases | N (%) | |
|---|---|---|
| No of patients | 22 | |
| Male:Female | 11 : 11 | 50 : 50 |
| Median Age, y, (Range) | 65 (35-77) | |
| Performance Status WHO | ||
| 0, 1, 2, 3, 4 | 6 / 10 / 3 / 2 / 1 | 27.0 / 45.5 / 14.0 / 9.0 / 4.5 |
| Primary Tumor | ||
| Pancreas | 2 | 9 |
| Esophagus/Cardia | 8 | 36 |
| Small Intestine | 2 | 9 |
| Colon | 1 | 5 |
| CUP (Cancer of unknown primary) | 9 | 41 |
| Chromogranin A Immunohistochemistry | ||
| Strongly positive / Positive/ Weakly positive/ Negative / Not Done | 4 / 8 / 7 / 1 / 2 | 18 / 36 / 32 / 5 / 9 |
| Synaptophysin Immunohistochemistry | ||
| Strongly positive / Positive/ Weakly positive/ Negative | 11 / 9 / 1 / 1 | 50 .0 / 41.0 / 4.5 / 4.5 |
| Somatostatin Receptor Scintigraphy | ||
| Strongly positive (>liver uptake) | 3 | 14.5 |
| Weakly Positive (<liver uptake) | 3 | 14.5 |
| Negative | 10 | 46.0 |
| Not done | 6 | 27.0 |
| Ki-67 | ||
| Median, %, (Range) | 95 (25-100) | |
| ≥ 55% | 17 | 77 |
| < 55% | 5 | 23 |
| Site of metastases | ||
| Liver | 11 | |
| Lymph nodes | 19 | |
| Brain | 3 | |
| Bone | 5 | |
| Pleural | 1 | |
| Lung | 3 | |
| Skin | 2 | |
| Breast | 1 | |
| Peritoneal, Retroperitoneal | 4 | |
| No. of metastatic sites | ||
| 1 | 7 | 32 |
| 2 | 7 | 32 |
| ≥3 | 8 | 36 |